Research Summaries

Rheumatoid Arthritis
Rheumatoid Arthritis
05/01/2017
Early treatment for rheumatoid arthritis (RA) is associated with improved long-term outcomes and mortality risk compared with later treatment.
05/01/2017
Rheumatoid Arthritis
Rheumatoid Arthritis
03/29/2017
A study aimed to quantify the risk of liver damage at varying levels of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
03/29/2017
Glucocorticoids
Glucocorticoids
03/08/2017
A recent study sought to determine the tolerability profile of glucocorticoids when used to treat early active rheumatoid arthritis.
03/08/2017
Bone fractures
Bone fractures
02/22/2017
An international expert panel published recommendations on the use of low-intensity pulsed ultrasound for accelerating the recovery of bone fractures or osteotomy.
02/22/2017
osteoarthritis
osteoarthritis
01/11/2017
A new study examined the effects of chair yoga on pain, pain interference, fatigue, and gait speed in older adults with lower extremity osteoarthritis
01/11/2017
Exercise
Exercise
01/09/2017
A study sought to determine the length of time of moderate-to-vigorous activity patients with osteoarthritis had to perform each week to sustain or improve function.
01/09/2017
Exercise
Exercise
12/09/2016
A recent study found that running decreases pro-inflammatory cytokine concentration in knees and can protect against degenerative joint disorders.
12/09/2016
Rheumatoid Arthritis
Rheumatoid Arthritis
11/18/2016
The PRECISION trial assessed the cardiovascular, gastrointestinal, and all-cause mortality effects of celecoxib compared with those of prescription-strength doses of ibuprofen and naproxen for the treatment...
11/18/2016
Rheumatoid Arthritis
Rheumatoid Arthritis
09/16/2016
New research finds a connection between initiating treatment for early rheumatoid arthritis with methotrexate plus a tumor necrosis factor inhibitor and a greater chance of retaining low disease activity...
09/16/2016
Research Summary
Research Summary
01/01/2015
Kate Young
In a recent study, interclass switching of biologic agents in psoriasis was associated with faster and more durable disease control, particularly when transitioning to anti–IL-23p19 therapies. However, the...
01/01/2015